Company Filing History:
Years Active: 2016
Title: Erin Finehout: Innovator in Alzheimer's Disease Diagnosis
Introduction
Erin Finehout is a notable inventor based in Kensington, MD (US). She has made significant contributions to the field of medical diagnostics, particularly in relation to Alzheimer's disease. Her innovative work focuses on developing methods for accurately diagnosing the disease state of individuals.
Latest Patents
Erin Finehout holds a patent for her invention titled "Multiplexed biomarkers for monitoring the Alzheimer's disease state of a subject." This invention relates to a method for diagnosing a subject's Alzheimer's disease state by utilizing a comprehensive database that contains information on protein expression levels associated with the disease. The database includes critical proteins such as albumin, apolipoprotein E, and vitamin D binding protein, among others. The method analyzes cerebrospinal fluid samples to provide a diagnosis, showcasing her commitment to advancing medical technology.
Career Highlights
Finehout's career is marked by her dedication to research and innovation. She is affiliated with the Cornell Research Foundation Inc., where she continues to work on groundbreaking projects that aim to improve diagnostic methods for Alzheimer's disease. Her contributions have been instrumental in enhancing the understanding of the disease and its biomarkers.
Collaborations
Throughout her career, Erin has collaborated with esteemed colleagues, including Kelvin Lee and Norman R Relkin. These partnerships have fostered a collaborative environment that encourages the exchange of ideas and expertise in the field of Alzheimer's research.
Conclusion
Erin Finehout's work exemplifies the impact of innovation in the medical field, particularly in the diagnosis of Alzheimer's disease. Her patent and ongoing research efforts contribute significantly to the advancement of healthcare solutions.